Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

411 studies match

clinicaltrialsPublishedShowing 201–250 of 411 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00375219	Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation	completed	Phase 2	103	Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY	10	Nov 15, 2021	clinicaltrials
NCT00865969	Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma(PTCL)	completed	Phase 2	129	Spectrum Pharmaceuticals, IncINDUSTRY	17	Oct 29, 2021